- Home
- FBIO vs GRCE Comparison
FBIO vs GRCE Comparison
Compare FBIO & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- GRCE
- Stock Information
- Founded
- FBIO 2006
- GRCE 2002
- Country
- FBIO United States
- GRCE United States
- Employees
- FBIO N/A
- GRCE N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- GRCE
- Sector
- FBIO Health Care
- GRCE
- Exchange
- FBIO Nasdaq
- GRCE NYSE
- Market Cap
- FBIO 49.1M
- GRCE 42.1M
- IPO Year
- FBIO N/A
- GRCE N/A
- Fundamental
- Price
- FBIO $1.88
- GRCE $3.13
- Analyst Decision
- FBIO Strong Buy
- GRCE Strong Buy
- Analyst Count
- FBIO 2
- GRCE 1
- Target Price
- FBIO $21.00
- GRCE $12.00
- AVG Volume (30 Days)
- FBIO 233.4K
- GRCE 55.8K
- Earning Date
- FBIO 08-12-2025
- GRCE 06-23-2025
- Dividend Yield
- FBIO N/A
- GRCE N/A
- EPS Growth
- FBIO N/A
- GRCE N/A
- EPS
- FBIO N/A
- GRCE N/A
- Revenue
- FBIO $57,784,000.00
- GRCE N/A
- Revenue This Year
- FBIO $51.59
- GRCE N/A
- Revenue Next Year
- FBIO $44.74
- GRCE N/A
- P/E Ratio
- FBIO N/A
- GRCE N/A
- Revenue Growth
- FBIO N/A
- GRCE N/A
- 52 Week Low
- FBIO $1.33
- GRCE $1.75
- 52 Week High
- FBIO $2.89
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- FBIO 53.63
- GRCE N/A
- Support Level
- FBIO $1.76
- GRCE N/A
- Resistance Level
- FBIO $1.89
- GRCE N/A
- Average True Range (ATR)
- FBIO 0.10
- GRCE 0.00
- MACD
- FBIO -0.01
- GRCE 0.00
- Stochastic Oscillator
- FBIO 75.00
- GRCE 0.00
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.